MP45-20 FSHR EXPRESSION ALLOWS ACCURATE DIFFERENTIATION OF BENIGN AND MALIGNANT RENAL NEOPLASMS: A PILOT STUDY
2021
INTRODUCTION AND OBJECTIVE:Our aim was to evaluate the expression of CD34 and FSHR in different renal cancers (RCa) and their ability in differentiating benign from malignant diseases.METHODS:A 10x...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI